I last reviewed Automatic Data Processing (ADP) in my January 26 post. Based on my analysis, I added a few additional shares at ~$225 in a retirement account where most of my ADP exposure is held; I do not disclose retirement account details. This explains why ADP was my 15th largest holding when I [...]
In my May 23 HEICO Corporation's (HEI and HEI.a) post, I disclose the purchase of 200 Class A non-voting shares @ ~$132/share. Upon further reflection, I have increased my HEICO exposure in the FFJ Portfolio with the purchase of another 100 shares at ~$127/share on May 26. This brings my exposure to 400 shares [...]
In this May 19, 2023 post, I disclose a new position in Thermo Fisher Scientific (TMO) with the purchase of 52 shares @ ~$515; I hold these shares in a 'Core' account within the FFJ Portfolio. On May 24, TMO held its 2023 Investor Day. Based on the information presented I acquired an additional [...]
HEICO Corporation's (HEI and HEI.a) total shareholder return over the past decade is very impressive. Although there is no assurance HEI can replicate what it has accomplished over the past decade, it has demonstrated that it has a winning formula. I am, therefore, willing to 'hitch my wagon to this horse'. Source: Tickertech.com [...]
In this May 10, 2023 Agilent Technologies (A) post, I disclose the addition of this Diagnostic & Research company to the FFJ Portfolio to go along with my exposure to Danaher Corporation (DHR); DHR posts are accessible through the Archives section of this site. I like the long-term outlook of the Diagnostic and Research industry. [...]
In previous posts, I have explained my rationale for investing in BlackRock (BLK) and Blackstone (BX) for the long term. I, therefore, dispense with a review of these two companies and merely provide this brief post to disclose the following additional purchases on May 9: BLK - acquired 30 shares @ $635.349 bringing my total [...]
This JP Morgan (JPM) post is my 4th guest post about North American banks at Dividend Power. The following are links to the previous 3 posts. Scotiabank (BNS) Is A Terrible Long-Term Investment TD Bank Is A Top 10 North American Bank CIBC Is An Accident Waiting To Happen All investments require the assessment [...]
I regret not having requested approval from my employers' compliance teams to permit me to invest in many of the companies with which I had dealings over the years as many of these companies have gone on to generate extremely attractive total investment returns. Agilent Technologies (A) is one such company. I initially became aware [...]
In my November 25, 2022 West Pharmaceutical (WST) post, I disclosed a new position in WST with the purchase of 100 shares @ ~$225/share in one of the 'Core' accounts within the FFJ Portfolio. I would have acquired a larger number of shares, however, I stated: 'In recent posts, I mention the purchase of a [...]